CLDI: Calidi Biotherapeutics Inc. Operatsion marja

Calidi Bio (CLDI) korporativ emblemasi va logotipi

Calidi Biotherapeutics (CLDI) ixcham ilmiy jamoa sifatida faoliyat yuritadi, virus ishlab chiqarish va sinovlarini tashqi pudratchilarga topshiradi. Ushbu EBIT marjasi grafigi operatsion daromadlilik tendentsiyalarini aks ettiradi, bunda 0.00 belgisi so'nggi ma'lumotlarni ifodalaydi. Garchi ushbu model R&D xizmatlarini autsorsing qilish orqali kapital xarajatlarni minimallashtirsa-da, daromadning yo'qligi va narxlarni belgilash imkoniyatining mavjud emasligi kompaniyani butunlay tashqi ventura moliyalashtirishiga bog'liq qilib qo'yadi.

CLDI - Calidi Biotherapeutics Inc. Operatsion foyda normasi 21.02.2024 - 19.11.2026 oraligʻida

CLDI (Calidi Bio): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning fundamental tahlili:Calidi Biotherapeutics
Calidi Biotherapeutics Inc. tayyor mahsulotlari

Calidi Biotherapeutics kompaniyasining viruslarni hujayralar orqali o'smalarga yetkazib berishning inqilobiy usullarini ishlab chiqishi ulkan R&D xarajatlarini talab qiladi, bu esa operatsion samaradorlikka bevosita ta'sir ko'rsatadi. Choraklik operatsion marjaning tahlili foizlar va soliqlar to'lanishidan oldin asosiy faoliyatdan olingan foyda ulushini baholash imkonini beradi, bu esa biznesning o'z innovatsiyalaridan pul oqimini yaratish qobiliyatini aniqlaydi, bu esa aktivning hayotiyligini baholash uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja SBFM|Xenetic Biosciences, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Salarius Pharmaceuticals SLRX|Operatsion marja purple-biotech.com PPBT|AONC - Operatsion rentabellik|BGNE: Operatsion rentabellik|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja